Healius Could Solve Near-Term Gearing Issue With Imaging Sale -- Market Talk

Dow Jones03-05

0101 GMT - Healius could solve its near-term gearing challenges by selling its imaging business, Citi analyst Mathieu Chevrier writes in a note. A sale of the imaging business could be the most likely outcome of the strategic review announced by Healius, although a partial sale of its pathology operations is also possible, he reckons. Using the ASX-listed Imdex for comparison, Chevrier thinks that Healius's imaging business could be worth A$525 million. This implies an enterprise value of A$700 million for pathology, which Chevrier tells clients looks too high given profitability and structural challenges that could take years to resolve. Citi has a last-published sell rating and A$1.10 target price on the stock, which is up 13% at A$1.275. (stuart.condie@wsj.com)

(END) Dow Jones Newswires

March 04, 2024 20:01 ET (01:01 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2417485368?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-03-05 09:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2417485368","market":"hk","top_or_hot":-1,"title":"Healius Could Solve Near-Term Gearing Issue With Imaging Sale -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0101 GMT - Healius could solve its near-term gearing challenges by selling its imaging business, Citi analyst Mathieu Chevrier writes in a note. A sale of the imaging business could be the most likely outcome of the strategic review announced by Healius, although a partial sale of its pathology operations is also possible, he reckons. Using the ASX-listed Imdex for comparison, Chevrier thinks that Healius's imaging business could be worth A$525 million. This implies an enterprise value of A$700 million for pathology, which Chevrier tells clients looks too high given profitability and structural challenges that could take years to resolve. Citi has a last-published sell rating and A$1.10 target price on the stock, which is up 13% at A$1.275. (stuart.condie@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 04, 2024 20:01 ET (01:01 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Healius Could Solve Near-Term Gearing Issue With Imaging Sale -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealius Could Solve Near-Term Gearing Issue With Imaging Sale -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-05 09:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>0101 GMT - Healius could solve its near-term gearing challenges by selling its imaging business, Citi analyst Mathieu Chevrier writes in a note. A sale of the imaging business could be the most likely...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HLS.AU","symbol_name":"HEALIUS LTD","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2417485368","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2417485368","pubTimestamp":1709600460,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0101 GMT - Healius could solve its near-term gearing challenges by selling its imaging business, Citi analyst Mathieu Chevrier writes in a note. A sale of the imaging business could be the most likely outcome of the strategic review announced by Healius, although a partial sale of its pathology operations is also possible, he reckons. Using the ASX-listed Imdex for comparison, Chevrier thinks that Healius's imaging business could be worth A$525 million. This implies an enterprise value of A$700 million for pathology, which Chevrier tells clients looks too high given profitability and structural challenges that could take years to resolve. Citi has a last-published sell rating and A$1.10 target price on the stock, which is up 13% at A$1.275. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HLS.AU":"HEALIUS LTD","BK7124":"保健护理服务","BK7509":"中概股","BK7501":"新冠治疗股"},"translate_title":"Healius可以通过影像销售解决近期杠杆问题——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HLS.AU":0.9},"content_text":"0101 GMT - Healius could solve its near-term gearing challenges by selling its imaging business, Citi analyst Mathieu Chevrier writes in a note. A sale of the imaging business could be the most likely outcome of the strategic review announced by Healius, although a partial sale of its pathology operations is also possible, he reckons. Using the ASX-listed Imdex for comparison, Chevrier thinks that Healius's imaging business could be worth A$525 million. This implies an enterprise value of A$700 million for pathology, which Chevrier tells clients looks too high given profitability and structural challenges that could take years to resolve. Citi has a last-published sell rating and A$1.10 target price on the stock, which is up 13% at A$1.275. (stuart.condie@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 04, 2024 20:01 ET (01:01 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2417485368"}